Bl. Williamson et al., ONLINE HPLC TANDEM MASS-SPECTROMETRY ANALYSIS OF CONTAMINANTS OF L-TRYPTOPHAN ASSOCIATED WITH THE ONSET OF THE EOSINOPHILIA-MYALGIA-SYNDROME, Toxicology letters, 92(2), 1997, pp. 139-148
The structural characterization of a number of contaminants of L-trypt
ophan (Trp) associated with eosinophilia myalgia syndrome has been per
formed for the first time by the powerful structural elucidation techn
ique of tandem mass spectrometry coupled with on-line HPLC (LC-ESI-MS/
MS). The identity of the contaminants: peaks UV-5, 3-(phenylamino)alan
ine, (PAA); E 1,1'-ethylidenebis(tryptophan); 200, 2-(3-indolylmethyl)
-L-tryptophan; (all identified as case related) and peaks 1, 3-carboxy
-1,2,3,4-tetrahydro-beta-carboline; 2, arboxy-1-methyl-1,2,3,4-tetrahy
dro-beta-carboline; 100, 2-(2,3 dihydroxy-1-[3-indolyl]propyl)-L-trypt
ophan; and 300 and 400, diastereomers of indolyl-methyl]-1,2,3,4-tetra
hydro-beta-carboline, have been confirmed by this technique. By compar
ison of tandem MS (MS/MS) data from these compounds with the MS/MS dat
a of several other impurities, we have structurally characterized peak
s CC, KK and OO, as well as two previously unreported components label
ed as peak P18 and peak P31. Peak P18 was unresolved from the large Tr
p peak and has been characterized as indole-3-ethylamine. Peak P31 was
previously unresolved from peak 200, a case related compound and ther
efore its structure is of extreme importance. This compound has been t
entatively identified as 2-(3-indolyl)-L-tryptophan. (C) 1997 Elsevier
Science Ireland Ltd.